000 01283 a2200361 4500
005 20250512060325.0
264 0 _c19870323
008 198703s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/BF00273405
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCantwell, B M
245 0 0 _aA phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1986
300 _a286-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarboplatin
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Evaluation
650 0 4 _aHumans
650 0 4 _aMesothelioma
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aOrganoplatinum Compounds
_xadverse effects
650 0 4 _aPleural Neoplasms
_xdrug therapy
650 0 4 _aRandom Allocation
700 1 _aFranks, C R
700 1 _aHarris, A L
773 0 _tCancer chemotherapy and pharmacology
_gvol. 18
_gno. 3
_gp. 286-8
856 4 0 _uhttps://doi.org/10.1007/BF00273405
_zAvailable from publisher's website
999 _c3547991
_d3547991